Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:48:46.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. This appears to be a software/version bump with no visible changes to study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-03-11T14:16:04.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page now shows a minor site revision label 'Revision: v3.4.2' and removes the prior 'Revision: v3.4.1' label, including a government funding status notice.
    Difference
    0.2%
    Check dated 2026-02-11T01:46:40.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    New documents and external references were added to the study page, including the Study Protocol PDF, Statistical Analysis Plan PDF, IPD sharing information, and publications from PubMed.
    Difference
    98%
    Check dated 2026-02-04T00:21:56.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deleted: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T00:14:21.000Z thumbnail image

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.